Raymond James Financial Services Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-8,635
| Closed | -$242K | – | 3257 |
|
|
2021
Q1 | $242K | Buy |
8,635
+715
| +9% | +$20K | ﹤0.01% | 2774 |
|
|
2020
Q4 | $206K | Hold |
7,920
| – | – | ﹤0.01% | 2694 |
|
|
2020
Q3 | $294K | Sell |
7,920
-5,850
| -42% | -$217K | ﹤0.01% | 2291 |
|
|
2020
Q2 | $707K | Sell |
13,770
-2,022
| -13% | -$104K | ﹤0.01% | 1697 |
|
|
2020
Q1 | $498K | Buy |
15,792
+3,131
| +25% | +$98.7K | ﹤0.01% | 1554 |
|
|
2019
Q4 | $755K | Buy |
12,661
+200
| +2% | +$11.9K | ﹤0.01% | 1709 |
|
|
2019
Q3 | $457K | Sell |
12,461
-173
| -1% | -$6.35K | ﹤0.01% | 1956 |
|
|
2019
Q2 | $588K | Sell |
12,634
-196
| -2% | -$9.12K | ﹤0.01% | 1818 |
|
|
2019
Q1 | $515K | Sell |
12,830
-490
| -4% | -$19.7K | ﹤0.01% | 1886 |
|
|
2018
Q4 | $613K | Buy |
+13,320
| New | +$613K | ﹤0.01% | 1535 |
|
|
2018
Q2 | – | Sell |
-3,870
| Closed | -$280K | – | 2762 |
|
|
2018
Q1 | $280K | Buy |
3,870
+505
| +15% | +$36.5K | ﹤0.01% | 2070 |
|
|
2017
Q4 | $222K | Buy |
+3,365
| New | +$222K | ﹤0.01% | 2186 |
|